Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Short-Sighted Ban Endangers Food Supply
This week, the Senate may vote on an amendment to the FDA Food Safety Modernization Act that could undermine the integrity of the U.S.
News Release
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors Court to Weigh In on Pharmaceutical Free Speech Washington, D.C.,…
Study
Truth or Consequences
The Benefits of Off-Label Drug and Device Promotion…
Newsletter
Household Chemicals, Fuel Efficiency, and “The Story of Stuff”
The website KeepitOrganic.org, which warns people about the dangers of using plastic products containing bisphenol A (BPA), is actually owned and operated by the Glass…
Op-Eds
Over the Counter Goes Under
"They won’t be so opposed to it once they see what’s in it." That’s the rationalization House leaders had given skittish Democrats to get…
Newsletter
Comcast v. FCC, Chemical Scares and Eminent Domain
The U.S. Court of Appeals’ decision in Comcast v. FCC limits the FCC’s power to enforce net neutrality. Time magazine publishes a list of “household…